Revised forecast
Fiscal year ending March 2026 · Full yearPrevious forecast published 13 February 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Sales declined due to the impact of the sales mix, while operating profit increased owing mainly to higher orders for contract processing and strong performance at certain overseas subsidiaries. Ordinary profit and profit attributable to owners of the parent increased due to higher equity in earnings of affiliates resulting from strong second-half performance at overseas affiliates, as well as foreign exchange translation gains at overseas subsidiaries.
Total impairment losses of ¥310 million (¥288 million for the Chemicals business and ¥22 million for the liquid dispersion business at the Saitama-Kodama Plant)
| Item | Details |
|---|---|
| Net Sales | ¥44,500 million → ¥42,224 million（-5.1%） |
| Operating profit | ¥1,200 million → ¥1,509 million（+25.8%） |
| Ordinary income | ¥1,350 million → ¥1,797 million（+33.1%） |
| Profit attributable to owners of the parent | ¥900 million → ¥1,159 million（+28.8%） |
| Net income per share | 573.40 yen and sen → 738.43 yen and sen |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 13 February 2026 |
| Previous-period results | Fiscal year ended March 2025: sales ¥37,921 million, operating profit ¥176 million, ordinary profit ¥402 million, profit attributable to owners of the parent ¥5,026 million, earnings per share ¥3,202.18 |
| Reason for the revision | Sales declined due to the impact of the sales mix, while operating profit increased owing mainly to higher orders for contract processing and strong performance at certain overseas subsidiaries. Ordinary profit and profit attributable to owners of the parent increased due to higher equity in earnings of affiliates resulting from strong second-half performance at overseas affiliates, as well as foreign exchange translation gains at overseas subsidiaries. |
| Details and amount of extraordinary loss | Total impairment losses of ¥310 million (¥288 million for the Chemicals business and ¥22 million for the liquid dispersion business at the Saitama-Kodama Plant) |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Sales declined due to the impact of the sales mix, while operating profit increased owing mainly to higher orders for contract processing and strong performance at certain overseas subsidiaries. Ordinary profit and profit attributable to owners of the parent increased due to higher equity in earnings of affiliates resulting from strong second-half performance at overseas affiliates, as well as foreign exchange translation gains at overseas subsidiaries. The impairment losses resulted from an assessment of the recoverability of fixed assets and the delayed recovery of profitability in the liquid dispersion business at the Saitama-Kodama Plant.